Prevalence of Staphylococcus aureus introduced into intensive care units of a university hospital

Brazilian Journal of Infectious Diseases

Volumn 9, Issue 1, 2005, Pages 56-63

  Cavalcanti, Silvana Maria De Morais ^a,b   De França, Emmanuel R ^a   Cabral, Carlos ^a   Vilela, Marinalda A ^a   Montenegro, Francisco ^a   Menezes, Daniela ^a   Medeiros, Ângela C R ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b NONE   (Brazil)

Author keywords

Intensive care unit; Methicillin resistant; Staphylococcus aureus

Indexed keywords

COAGULASE; DEOXYRIBONUCLEASE;

ADOLESCENT; ADULT; AGED; AGGLUTINATION TEST; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BODY FLUID; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CULTURE MEDIUM; ENZYME ANALYSIS; GRAM STAINING; HOSPITALIZATION; HUMAN; IMMUNOTHERAPY; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NOSE CARTILAGE; PERINEUM; PREVALENCE; RISK FACTOR; SCHOOL CHILD; SKIN DEFECT; STAPHYLOCOCCUS AUREUS; UNIVERSITY HOSPITAL; AGE DISTRIBUTION; BRAZIL; CHILD; CROSS INFECTION; DRUG EFFECT; FEMALE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; PENICILLIN RESISTANCE; STAPHYLOCOCCUS INFECTION; STATISTICS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; BRAZIL; CHILD; CROSS INFECTION; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE UNITS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; PREVALENCE; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 26044438478     PISSN: 14138670     EISSN: 14138670     Source Type: Journal    
DOI: 10.1590/S1413-86702005000100010     Document Type: Article

References (30)

1. Centers for Disease Control and Prevention. Multidrug-resistant organisms in Non- Hospital Healthcare settings. December 2000. Available at 〈http:// www.cdc.gov/ncidod/hip/Aresit/nonhosp.htm〉. Accessed 03/12/2002.
2. Centers for Disease Control and Prevention. Laboratory detection of oxacillin/methicillin-resistant Staphylococcus aureus (MRSA). Dec. 1999. Available at 〈http:// www.cdc.gov/ncidod/hip/Lab/FactSheet/mrsa.htm〉. Accessed 04/12/2002.
3. Lowy F.D. Staphylococcus aureus infections. N Engl J Med 1998;339:520-32.
4. Pedro R.J., Branchini M.L. M. Estafilococcias. In. Veronesi R., Focaccia R. Tratado de Infectologia. São Paulo: Atheneu, 1996:654-65.
5. a ed. Rio de Janeiro: Guanabara Koogan, 1997:163-73.
6. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a State Prison-Mississippi, 2000. MMWR Morb Mortal Weekly Rep 2001;50:919-22.
7. Elliot M.J., Kellun M.T., Tenover F.C., Pettriess R.L. Nasal carriage of methicillin-resistant Staphylococcus aureus among paramedics in the Sedgwick Medical Service in Wichita, Kansas. Infect Control Hosp Epidemiol 2002;23:60-3.
8. Boyce J.M. Preventing infections by eradicating nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 1996;17:1-5.
9. Tammelin A., Klotz F., Hambraeus A., et al. Nasal and hand carriage of Staphylococcus aureus in staff at a Department for Thoracic and Cardiovascular Surgery: endogenous or exogenous source? Infect Control Hosp Epidemiol 2003;24:686-9.
10. Canadian Paediatric Society-Infectious Diseases and Immunization Committee. Control of methicillin-resistant Staphylococcus aureus in Canadian pediatric institutions is still a worthwhile goal. Paediat Child Health 1999;4:337-41.
11. Vandenbergh M.F.Q., Verbrugh H.A. Carriage of Staphylococcus aureus: epidemiology and clinical relevance. J Lab Clin Med 1999;133:525-34.
12. Shuter J., Hatcher V.B., Lowy F.D. Staphylococcus aureus binding to human nasal mucin. Infect Immun 1996;64:310-8.
13. Perl T.M., Cullen J.J., Wenzel R.P., et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002;346:1871-7.
14. Lowy F.D. Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 2003;111:1265-73.
15. Stapleton P.D., Taylor P.W. Methicillin resistance in Staphylococcus aureus: mechanisms and modulation. Sci Progr 2002;85:57-72.
16. Korn G.P., Martino M.D.V., Mimica I.M., et al. High frequency of colonization and absence of identifiable risk factors for methicillin-resistant Staphylococcus aureus (MRSA) in intensive care units in Brazil. Braz J Infect Dis 2001;5:1-7.
17. Vriens M.R., Fluit C., Troelstra A., et al. Is methicillin-resistant Staphylococcus aureus more contagious than methicillin-susceptible S. aureus in a surgical intensive care unit? Infect Control Hosp Epidemiol 2002;23:491-5.
18. Katayama Y., Ito T., Hiramatsu K. A new class of genetic element, Staphylococcus Cassete Chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicr Ag Chemoth 2000;44:1549-55.
19. Vandenbergh M.F.Q., Yzerman E.D.P.F., Belkun A., et al. Follow-up of Staphylococcus aureus nasal carriage after 8 years: redefining the persistent carrier state. J Clin Microbiol 1999;37:3133-40.
20. Haddadin A.S., Fappiano S.A., Lipsett P.A. Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit. Postgrad Med J 2002;78:385-96.
21. Lucet J.C., Chevret S., Zaleski I.D., et al. Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit. Arch Intern Med 2003;163:181-8.
22. Centers for Disease Control and Prevention. MRSA - methicillin resistant Staphylococcus aureus. March 2003. Available at: www.cdc.gov. Acessed March 06, 2003.
23. Scanvc A., Denic L., Gaillon S., et al. Duration of colonization by methicillin resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage. Clin Infect Dis 2001;32:1393.
24. Chaix C., Durand-Zaleski I., Alberti C., Brun-buisson C. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 1999;282:1745-51.
25. Girou E., Pujade G., Legrand P., et al. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis, Toronto 1998;27:543-50.
26. Girou E., Azar J., Wolkenstein P., et al. Comparison of systematic versus selective screening for methicillin-resistant Staphylococcus aureus carriage in a high-risk dermatology ward. Infect Control Hosp Epidemiol 2000;21:583-90.
27. Porter R., Subramani K., Thomas A.N., Chadwick P. Nasal carriage of Staphylococcus aureus on admission to intensive care: incidence and prognostic significance. Intensive Care Med 2003;29:655-8.
28. Kluytmans J., Van Belkum A., Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying, mechanisms, and associated risks. Clin Microbiol Rev 1997;10:505-20.
29. Kenner J., O'Connor T., Piantanida N., et al. Rates of carriage of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in an outpatient population. Infect Control Hosp Epidemiol 2003;24:439-44.
30. Nguyen M.H., Kauffman C.A., Goodman R.P., et al. Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med 1999;130:221-5.